Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-03-31 Sale |
2025-04-02 5:00 pm |
AbbVie Inc. | ABBV | Stewart Jeffrey Ryan EVP, CHIEF COMMERCIAL OFFICER |
58,832 | $210.08 | $12,359,504 | 54,572 (Indirect Direct) |
View |
| 2024-03-18 Sale |
2024-03-20 5:00 pm |
AbbVie Inc. | ABBV | Stewart Jeffrey Ryan EVP, CHIEF COMMERCIAL OFFICER |
58,949 | $178.79 | $10,539,508 | 62,279 (Indirect Direct) |
View |
| 2023-03-13 Sale |
2023-03-15 5:00 pm |
AbbVie Inc. | ABBV | Stewart Jeffrey Ryan EVP, CHIEF COMMERCIAL OFFICER |
53,125 | $152.28 | $8,089,998 | 62,279 (Indirect Direct) |
View |
| 2022-03-24 Sale |
2022-03-25 5:09 pm |
AbbVie Inc. | ABBV | Stewart Jeffrey Ryan EVP, Chief Commercial Officer |
27,690 | $159.2 | $4,408,375 | 62,279 (Indirect Direct) |
View |
| 2022-03-01 Sale |
2022-03-01 6:08 pm |
AbbVie Inc. | ABBV | Stewart Jeffrey Ryan EVP, Chief Commercial Officer |
21,488 | $148.25 | $3,185,599 | 62,279 (Indirect Direct) |
View |
| 2021-12-15 Sale |
2021-12-17 5:01 pm |
AbbVie Inc. | ABBV | Stewart Jeffrey Ryan EVP, Chief Commercial Officer |
2,152 | $128 | $275,456 | 48,442 (Indirect Direct) |
View |
| 2021-03-01 Sale |
2021-03-02 8:26 pm |
AbbVie Inc. | ABBV | Stewart Jeffrey Ryan SVP, US Commercial Operations |
13,773 | $108.59 | $1,495,576 | 52,307 (Indirect Direct) |
View |
| 2020-12-29 Sale |
2020-12-31 1:15 pm |
AbbVie Inc. | ABBV | Stewart Jeffrey Ryan EVP, Commercial Operations |
25,290 | $105 | $2,655,450 | 52,307 (Indirect Direct) |
View |
| 2020-05-12 Sale |
2020-05-12 5:44 pm |
AbbVie Inc. | ABBV | Stewart Jeffrey Ryan SVP, US Commercial Operations |
23,024 | $90 | $2,072,211 | 54,098 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-03-31 Exercise |
2025-04-02 5:00 pm |
N/A 2029-02-20 |
AbbVie Inc. | ABBV | Stewart Jeffrey Ryan EVP, CHIEF COMMERCIAL OFFICER |
25,700 | $79.02 | 54,572 (Direct) |
View |
| 2025-02-28 Tax Withholding |
2025-03-04 5:00 pm |
N/A N/A |
AbbVie Inc. | ABBV | Stewart Jeffrey Ryan EVP, CHIEF COMMERCIAL OFFICER |
20,226 | $205.02 | 87,704 (Direct) |
View |
| 2025-02-13 Option Award |
2025-02-18 5:00 pm |
N/A 2035-02-12 |
AbbVie Inc. | ABBV | Stewart Jeffrey Ryan EVP, CHIEF COMMERCIAL OFFICER |
79,505 | $0 | 141,784 (Direct) |
View |
| 2024-03-18 Exercise |
2024-03-20 5:00 pm |
2018-02-16 2027-02-15 |
AbbVie Inc. | ABBV | Stewart Jeffrey Ryan EVP, CHIEF COMMERCIAL OFFICER |
26,110 | $61.36 | 62,279 (Direct) |
View |
| 2024-02-28 Tax Withholding |
2024-03-01 5:50 pm |
N/A N/A |
AbbVie Inc. | ABBV | Stewart Jeffrey Ryan EVP, CHIEF COMMERCIAL OFFICER |
26,121 | $178.99 | 95,118 (Direct) |
View |
| 2024-02-15 Option Award |
2024-02-20 5:15 pm |
2025-02-15 2034-02-14 |
AbbVie Inc. | ABBV | Stewart Jeffrey Ryan EVP, CHIEF COMMERCIAL OFFICER |
98,045 | $0 | 160,324 (Direct) |
View |
| 2023-03-13 Exercise |
2023-03-15 5:00 pm |
2017-02-18 2026-02-17 |
AbbVie Inc. | ABBV | Stewart Jeffrey Ryan EVP, CHIEF COMMERCIAL OFFICER |
21,810 | $54.86 | 62,279 (Direct) |
View |
| 2023-02-28 Tax Withholding |
2023-03-02 5:02 pm |
N/A N/A |
AbbVie Inc. | ABBV | Stewart Jeffrey Ryan EVP, COMMERCIAL OPERATIONS |
24,910 | $154.28 | 93,594 (Direct) |
View |
| 2023-02-16 Option Award |
2023-02-21 6:02 pm |
2024-02-16 2033-02-15 |
AbbVie Inc. | ABBV | Stewart Jeffrey Ryan EVP, COMMERCIAL OPERATIONS |
91,336 | $0 | 153,615 (Direct) |
View |
| 2022-03-24 Exercise |
2022-03-25 5:09 pm |
2016-02-19 2025-02-18 |
AbbVie Inc. | ABBV | Stewart Jeffrey Ryan EVP, Chief Commercial Officer |
27,690 | $58.88 | 62,279 (Direct) |
View |
| 2022-02-25 Tax Withholding |
2022-03-01 6:08 pm |
N/A N/A |
AbbVie Inc. | ABBV | Stewart Jeffrey Ryan EVP, Chief Commercial Officer |
17,093 | $149.54 | 62,279 (Direct) |
View |
| 2022-02-17 Option Award |
2022-02-22 5:42 pm |
2023-02-17 2032-02-16 |
AbbVie Inc. | ABBV | Stewart Jeffrey Ryan EVP, Chief Commercial Officer |
89,633 | $0 | 138,075 (Direct) |
View |
| 2021-12-10 Tax Withholding |
2021-12-14 5:00 pm |
N/A N/A |
AbbVie Inc. | ABBV | Stewart Jeffrey Ryan EVP, Chief Commercial Officer |
1,713 | $124.15 | 50,594 (Direct) |
View |
| 2021-02-28 Tax Withholding |
2021-03-02 8:26 pm |
N/A N/A |
AbbVie Inc. | ABBV | Stewart Jeffrey Ryan SVP, US Commercial Operations |
10,957 | $107.74 | 52,307 (Direct) |
View |
| 2021-02-18 Option Award |
2021-02-22 6:19 pm |
2022-02-18 2031-02-17 |
AbbVie Inc. | ABBV | Stewart Jeffrey Ryan SVP, US Commercial Operations |
68,208 | $0 | 120,515 (Direct) |
View |
| 2020-12-29 Exercise |
2020-12-31 1:15 pm |
N/A N/A |
AbbVie Inc. | ABBV | Stewart Jeffrey Ryan EVP, Commercial Operations |
25,290 | $51.42 | 52,307 (Direct) |
View |
| 2020-12-29 Exercise |
2020-12-31 1:15 pm |
2015-02-20 2024-02-19 |
AbbVie Inc. | ABBV | Stewart Jeffrey Ryan EVP, Commercial Operations |
25,290 | $0 | 52,307 (Direct) |
View |
| 2020-12-10 Tax Withholding |
2020-12-11 4:31 pm |
N/A N/A |
AbbVie Inc. | ABBV | Stewart Jeffrey Ryan SVP, US Commercial Operations |
1,791 | $108.67 | 52,307 (Direct) |
View |